67509-13-1

Basic information

• Product Name: N-AcetylAngiotensinI(Human)
• Synonyms: N-Acetylangiotensini(Human)
• CAS NO: 67509-13-1
• Molecular Formula: C64H91N17O15
• Molecular Weight: 1338.53
• Mol File: 67509-13-1.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: N-AcetylAngiotensinI(Human)(CAS DataBase Reference)
• NIST Chemistry Reference: N-AcetylAngiotensinI(Human)(67509-13-1)
• EPA Substance Registry System: N-AcetylAngiotensinI(Human)(67509-13-1)

Safety Data

• Hazardous Substances Data: 67509-13-1(Hazardous Substances Data)

Usage

Description

N-AcetylAngiotensinI(Human), also known as angiotensin I, is a naturally occurring peptide hormone found in the human body. It is derived from angiotensinogen, a precursor protein produced by the liver. Angiotensin I is an important component of the renin-angiotensin-aldosterone system, which helps to regulate blood pressure and fluid balance in the body. It is also involved in the regulation of sodium and water reabsorption in the kidneys. Angiotensin I is a precursor to angiotensin II, a potent vasoconstrictor that further regulates blood pressure. Overall, N-AcetylAngiotensinI(Human) plays a crucial role in maintaining cardiovascular and renal function in the body.

Uses

Used in Pharmaceutical Industry:
N-AcetylAngiotensinI(Human) is used as a research tool for studying the renin-angiotensin-aldosterone system and its role in blood pressure regulation and fluid balance. It aids in the development of drugs targeting this system for the treatment of hypertension and related cardiovascular conditions.
Used in Biomedical Research:
N-AcetylAngiotensinI(Human) is used as a bioactive peptide in research to understand its role in the regulation of sodium and water reabsorption in the kidneys. This knowledge can contribute to the development of therapies for kidney diseases and disorders related to fluid balance.
Used in Diagnostic Applications:
N-AcetylAngiotensinI(Human) can be used as a diagnostic marker to assess the functionality of the renin-angiotensin-aldosterone system in patients. This can help in identifying individuals at risk for hypertension and other cardiovascular diseases, enabling early intervention and treatment.